Arguments surrounding first-of-its-kind legislation that categorizes two widely used abortion -inducing drugs as “controlled dangerous substances” in Louisiana are scheduled to take place before a state judge Thursday morning.
In a lawsuit against the state, plaintiffs say the reclassification of misoprostol and mifepristone — which have critical reproductive health care uses in addition to being used as a two-drug regimen to end pregnancies — could cause needless and potentially life-threatening delays in treatment during medical emergencies.
